Retina

Print ISSN
0275-004X
Electronic ISSN
1539-2864
Impact factor
2.774
Publisher
LWW
URL
http://journals.lww.com/retinajournal
Usage rank
3113
Article count
4668
Free count
13
Free percentage
0.00278492
PDFs via platforms
Ovid from 2001 and LWW

  1. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.

    Retina 28(6):894 (2008) PMID 18536609

    Deferoxamine (DFO) is a chelating agent used widely for the treatment of transfusional hemochromatosis. DFO-related ocular toxicity has been previously reported several times, and many institutions have adopted an ophthalmic screening protocol for patients treated with DFO despite little informa...
  2. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.

    Retina 28(6):808 (2008) PMID 18536596

    To determine the distribution of macular pigment in type 2 idiopathic macular telangiectasia (IMT). Twenty-two eyes of 12 patients with type 2 IMT were examined by means of best-corrected visual acuity testing, fundus biomicroscopy, fundus photography, fluorescein angiography, and optical cohere...
  3. Pediatric rhegmatogenous retinal detachment: clinical features and surgical outcomes.

    Retina 28(6):847 (2008) PMID 18536601

    To describe the characteristics of and surgical outcomes for primary pediatric rhegmatogenous retinal detachment (RRD) and to evaluate whether specific characteristics impact anatomical outcomes after surgical intervention. Data for consecutive patients (18 years of age or younger) with RRD who ...
  4. The optical coherence tomography-ophthalmoscope for examination of central serous chorioretinopathy with precipitates.

    Retina 28(6):864 (2008) PMID 18536604

    To report the exact location of multiple yellowish dot-like precipitates in central serous chorioretinopathy (CSC) with the Optical Coherence Tomography (OCT)-Ophthalmoscope (Nidek-OTI, Gamagori, Japan). Retrospective, observational study. Twenty eyes of 18 patients (average age, 53 years) with ...
  5. The effect of treatments given to patients before initiation of anti-vascular endothelial growth factor treatment.

    Retina 28(6):911 (2008) PMID 18536615

  6. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

    Retina 28(6):831 (2008) PMID 18536599

    To report a retrospective, consecutive, noncomparative case series of moderate and severe stage 3 retinopathy of prematurity (ROP) in zone I or posterior zone II treated by bilateral intravitreal injections of bevacizumab (Avastin; Genentech, Inc., South San Francisco, CA). Eleven infants weighi...
  7. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.

    Retina 28(6):817 (2008) PMID 18536597

    To investigate the mechanism of angiogenesis in proliferative diabetic retinopathy (PDR) and Eales' disease (ED) on the basis of the levels of proinflammatory cytokines, angiogenic growth factor, and antiangiogenic factor in the vitreous humor. Twenty-five patients with PDR, 10 patients with ED,...
  8. Lipocalin-like prostaglandin D synthase in subretinal fluid of detached retinas in humans.

    Retina 28(6):858 (2008) PMID 18536603

    The presence of lipocalin-like prostaglandin D synthase (L-PGDS), a dominantly brain derived protein in the cerebrospinal fluid (CSF) with a low concentration in serum, in the subretinal fluid (SRF) of detached retinas, has not been reported. L-PGDS has been demonstrated in the ciliary body and ...
  9. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).

    Retina 28(6):910; author reply 910 (2008) PMID 18536613

  10. A method of reporting macular edema after cataract surgery using optical coherence tomography.

    Retina 28(6):870 (2008) PMID 18536605

    To validate a method of reporting postcataract macular edema (ME) using optical coherence tomography (OCT). : Data were analyzed for 130 eyes followed prospectively for ME after uncomplicated cataract surgery. Each eye underwent OCT within 4 weeks before surgery and at 1 month and 3 months after...
  11. Autofluorescence in adult-onset foveomacular vitelliform dystrophy.

    Retina 28(6):801 (2008) PMID 18536595

    To describe fundus autofluorescence (FAF) characteristics of adult-onset foveomacular vitelliform dystrophy (AOFVD) and to perform a comparative evaluation of FAF patterns and functional response. Fifteen patients with AOFVD and 10 healthy volunteers underwent complete ophthalmic examination, in...
  12. Retinal function and loss of autofluorescence in stargardt disease.

    Retina 28(6):794 (2008) PMID 18536594

    To determine the relationship between reduced retinal autofluorescence and the dense scotomas in Stargardt disease. Retrospective review of patients with Stargardt disease seen between 2000 and 2004 at a tertiary referral center. All 32 patients with Stargardt who underwent both autofluorescence...
  13. Diagnostic and therapeutic challenges.

    Retina 28(6):904 (2008) PMID 18536611

  14. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes.

    Retina 28(6):839 (2008) PMID 18536600

    To examine the anatomical and refractive outcomes of infrared diode laser photocoagulation (DLPC) for the treatment of threshold retinopathy of prematurity (ROP). The charts of all consecutive premature neonates with ROP treated by DLPC at our tertiary center from December 1, 1996, to December 3...
  15. Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections.

    Retina 28(6):877 (2008) PMID 18536606

    To evaluate potential sources of bacterial contamination during intravitreal (IVT) injection procedures. Patients scheduled for IVT injection were asked to enroll in the study at the California Vitreoretinal Center (Menlo Park, CA) and the Vantage Eye Center (Salinas, CA) between October 2004 an...
  16. Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration.

    Retina 28(6):789 (2008) PMID 18536593

    To evaluate combination treatment with reduced-fluence photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVT) injection for choroidal neovascularization (CNV) in age-related macular degeneration (AMD). This is a retrospective consecutive case series of 23 previously untreated ...
  17. Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.

    Retina 28(6):825 (2008) PMID 18536598

    To compare the efficacy and safety of different doses of intravitreal triamcinolone (IVTA) in treating eyes with refractory diffuse diabetic macular edema (DME) with cystic changes. Forty-five eyes of 45 patients with diffuse DME were randomized to receive 1, 2, or 4 mg IVTA. Patients were obser...
  18. A new scleral plug with shouldered-stop for use during vitrectomy.

    Retina 28(6):908 (2008) PMID 18536612

  19. Long-term follow-up results of ilm peeling during vitrectomy surgery for premacular fibrosis.

    Retina 28(6):853 (2008) PMID 18536602

    To evaluate the outcomes of surgical removal of premacular fibrosis (PMF) with peeling of the internal limiting membrane (ILM). Determination of factors associated with favorable outcomes (visual acuity between 20/20 and 20/40). Retrospective chart review, evaluating visual outcomes in 38 patien...
  20. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.

    Retina 28(6):889 (2008) PMID 18536608

    Uveitis and scleritis are the most serious ocular side effects of bisphosphonate therapy. The purpose of this study was to determine the 6-month rates of uveitis/scleritis following dispensing of bisphosphonates in a large veteran cohort. Two national databases (clinical and pharmacy) for fiscal...